Voyager Therapeutics (VYGR) Revenue (2015 - 2026)
Voyager Therapeutics recorded quarterly Revenue of $2.6 million in Q1 2026, down 83.13% quarter-over-quarter from $15.4 million in Q4 2025, and down 60.11% year-over-year from $6.5 million in Q1 2025.
Voyager Therapeutics' Revenue history runs 12 years deep, the most recent figure standing at $2.6 million for Q1 2026.
- In Q1 2026, Revenue fell 60.11% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $36.6 million (down 45.45% YoY), while the FY2025 annual figure was $40.4 million, down 49.53% from the prior year.
- Revenue came in at $2.6 million for Q1 2026 at Voyager Therapeutics, down from $15.4 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $150.5 million in Q1 2023 to a low of -$1.5 million in Q4 2022.
- A 5-year average of $24.4 million and a median of $6.5 million in 2025 frame the typical range for Revenue.
- Across the five-year window, Revenue tumbled 105.52% in 2022 and surged 22769.3% in 2023, its largest moves.
- Voyager Therapeutics' Revenue stood at -$1.5 million in 2022, then jumped by 5913.42% to $90.1 million in 2023, then sank by 93.01% to $6.3 million in 2024, then jumped by 143.99% to $15.4 million in 2025, then plunged by 83.13% to $2.6 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $2.6 million, $15.4 million, and $13.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - | 2.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | 15.37 Mn |
| Sep 30, 2025 | 13.40 Mn |
| Jun 30, 2025 | 5.20 Mn |
| Mar 31, 2025 | 6.50 Mn |
| Dec 31, 2024 | 6.30 Mn |
| Sep 30, 2024 | 24.63 Mn |
| Jun 30, 2024 | 29.60 Mn |
| Mar 31, 2024 | 19.50 Mn |
| Dec 31, 2023 | 90.11 Mn |
| Sep 30, 2023 | 4.60 Mn |
| Jun 30, 2023 | 4.90 Mn |
| Mar 31, 2023 | 150.48 Mn |
| Dec 31, 2022 | -1.55 Mn |
| Sep 30, 2022 | 41.09 Mn |
| Jun 30, 2022 | 712,000.00 |
| Mar 31, 2022 | 658,000.00 |
| Dec 31, 2021 | 28.07 Mn |
| Sep 30, 2021 | 1.48 Mn |
| Jun 30, 2021 | 1.36 Mn |
| Mar 31, 2021 | 6.50 Mn |
| Dec 31, 2020 | 6.54 Mn |
| Sep 30, 2020 | 117.84 Mn |
| Jun 30, 2020 | 28.68 Mn |
| Mar 31, 2020 | 18.07 Mn |
| Dec 31, 2019 | 32.67 Mn |
| Sep 30, 2019 | 20.43 Mn |
| Jun 30, 2019 | 46.09 Mn |
| Mar 31, 2019 | 5.20 Mn |
| Dec 31, 2018 | 2.01 Mn |
| Sep 30, 2018 | 2.09 Mn |
| Jun 30, 2018 | 2.58 Mn |
| Mar 31, 2018 | 942,000.00 |
| Dec 31, 2017 | 6.35 Mn |
| Sep 30, 2017 | 1.15 Mn |
| Jun 30, 2017 | 1.18 Mn |
| Mar 31, 2017 | 1.46 Mn |
| Dec 31, 2016 | 2.36 Mn |
| Sep 30, 2016 | 3.31 Mn |
| Jun 30, 2016 | 3.72 Mn |
| Mar 31, 2016 | 4.83 Mn |
| Dec 31, 2015 | 4.94 Mn |
| Sep 30, 2015 | 4.94 Mn |
| Jun 30, 2015 | 4.88 Mn |
| Mar 31, 2015 | 2.58 Mn |